A new research paper has been published in Aging entitled "The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability."
Nov 22, 2022
0
0
Researchers have puzzled over the neurodegenerative disorder Alzheimer's disease for decades, but treatments to stop or reverse the disease's effects on the brain have remained elusive. Scientists at St. Jude Children's ...
Oct 13, 2022
0
56
Babies with leukemia could get an array of new treatments after scientists used genetic engineering to reproduce a gene defect found in the disease.
Oct 7, 2022
0
64
High Framingham risk score (FRS) categories are seen among women with a history of migraine, but not for those with active migraine at baseline or during follow-up, according to a study published online Aug. 19 in Neurology.
Oct 6, 2022
0
10
The prevalence, age of onset, and clinical symptoms for virtually all neuropsychiatric disorders differ between men and women. Among the disorders with pronounced sex bias are Attention-Deficit/Hyperactivity Disorder (ADHD) ...
Sep 21, 2022
0
43
Researchers at Linköping University, Sweden, have discovered a biological mechanism that increases the strength with which fear memories are stored in the brain. The study, carried out in rats, is published in Molecular ...
Sep 20, 2022
0
116
Does aspirin increase survival in cancer patients? UK researchers say that despite the smaller side-effects of aspirin, taking the drug has an overall positive effect on survival for people with cancer. The team reviewed ...
Sep 14, 2022
0
13
Nearly 6 million older adults have Alzheimer's disease in the United States, a number expected to double by 2050. Already the sixth leading cause of death, Alzheimer's disease is a complex neurodegenerative disease that causes ...
Jun 24, 2022
0
47
Cedars-Sinai investigators have identified a gene that plays an essential role in the innate human immune system. The gene, NLRP11, helps activate the inflammatory response that tells the body's white blood cells to go on ...
Jun 2, 2022
0
89
For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...
May 25, 2022
0
11
